Not an emergency service. In an emergency, contact local emergency services now.
China Care
All news

Lymphoma · CAR-T access

New Zealand Shanghai

When lymphoma closed one trial route, a young New Zealander looked to Shanghai

Michael Walters’s route to CAR-T was shaped by disease progression as well as cost. Access to a local research programme had narrowed before Shanghai became an option.

By China Care EditorialBased on published reporting
The condition
Aggressive non-Hodgkin lymphoma
The medical resource
CAR-T at SinoUnited Hospital
The journey
Treatment after unsuccessful earlier therapies

A local trial was no longer an option

Newstalk ZB reported in June 2026 that the young Auckland man’s aggressive lymphoma had spread too quickly for a New Zealand trial he had hoped to join. His family was considering overseas CAR-T and fundraising to meet the cost.

[1] Newstalk ZB

What later reporting found in Shanghai

Wall Street Journal reporting, published in German by BILANZ, described unsuccessful chemotherapy, radiotherapy and immunotherapy before Walters chose SinoUnited Hospital in Shanghai. It reported complete remission in August. The article also makes clear that a lower overseas treatment price materially influenced his choice.

[2] The Wall Street Journal, via BILANZ

China Care perspective

What this case helps us understand

Walters’s story connects access to treatment with the changing course of an aggressive disease. A Shanghai team provided a treatment setting after earlier therapies and a hoped-for local trial had failed to provide a route forward. Both clinical eligibility and affordability shaped the journey. His reported remission is a dated outcome that gives the story substance, with future recovery requiring continued follow-up.

Sources & further reading

Original reporting belongs to the publishers below. This article is an independently written account based on those sources, with editorial interpretation identified above.

  1. Newstalk ZB · Media reporting · English‘Enjoy your life’: Young Auckland man faces $500k fight for cancer therapy overseas (opens in a new tab)

    Indexed publisher text; local trial exclusion and planned overseas treatment

  2. The Wall Street Journal, via BILANZ · Syndicated media reporting · German, translated by BILANZ from EnglishPatienten fliegen für die neueste Krebsbehandlung nach China (opens in a new tab)

    Jonathan Cheng’s report in the publisher’s German edition; treatment, price and remission

China Care did not provide the care described. This story does not imply a relationship with the patient or hospital, or that China Care can arrange the same treatment. Individual outcomes do not predict other patients’ results. This is editorial information, not medical advice.

Published by China Care on 29 October 2026. Patient experiences and treatment access reflect the dates of the cited reporting.

View all stories